Selected Publications from Joslin Faculty: January and February 2025
Joslin-Led Academic Publications
The premiere research institution dedicated entirely to diabetes, Joslin is driving the innovation and discovery that will bring us closer to a cure. Each year, Joslin’s 250-plus researchers across 27 labs publish hundreds of peer-reviewed papers in high-impact journals, reinforcing its reputation as a trusted leader in diabetes research relied upon by clinicians and scientists worldwide. This issue of Selected Publications highlights academic works led by Joslin community members in January and February 2025.
Reduced Aqueous Retinol-Binding Protein 3 Concentration Is Associated With Diabetic Macular Edema and Progression of Diabetic Retinopathy
Diabetes Care / Original Article / Jan 1
BILH Authors Tanvi Chokshi, Ward Fickweiler, Surya Jangolla, Kyoungmin Park, I-Hsien Wu, Hetal Shah, Jennifer K Sun, Lloyd Paul Aiello, George L King
Retinopathy Lesion Types and Distribution on Ultrawide Field Imaging and The Risk of Disease Worsening Over Time
Retina / Observational Study / Jan 1
BILH Authors Paolo S Silva, Lloyd P Aiello, Jennifer K Sun
A Lactobacillus consortium provides insights into the sleep-exercise-microbiome nexus in proof of concept studies of elite athletes and in the general population
Microbiome / Research / Jan 2
BILH Authors Aleksandar D Kostic
Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
J Am Soc Nephrol / Perspective / Jan 7
BILH Authors Alessandro Doria
Divergent roles of m6A in orchestrating brown and white adipocyte transcriptomes and systemic metabolism
Nat Comm / Article / Jan 9
BILH Authors Ling Xiao, Dario F De Jesus, Jiang Hu, Ava DiStefano-Forti, Valeria Salerno Gonzales, Tadataka Tsuji, Siying Wei, Yu-Hua Tseng, Rohit N Kulkarni
Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women
Diabetologia / Article / Jan 14
BILH Authors Qi Sun
Comparing demographic/clinical characteristics, health care resource utilization, and costs among patients with type 2 diabetes and established atherosclerotic cardiovascular disease with and without the use of cardioprotective medications
J Manag Care Spec Pharm / Research Article / Jan 17
BILH Authors Joanna Mitri
Diabetes visits in paediatric versus adult clinics for young adults (YA) with T1D: Pre-pandemic and pandemic care
Diabetes Med / Research Article / Jan 18
BILH Authors Amit Shapira, Liane J Tinsley, Elena Toschi, Lori M Laffel
Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real-world evidence from a 22-year follow-up study
Diabetes Obes Metab / Research Letter / Jan 22
BILH Authors Tarunveer S Ahluwalia
Is Weight Loss the Main Driver for A1C Improvement by Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists? A 2.5-Year Analysis in Real-World Clinical Practice
J Diabetes / Original Article / Jan 23
BILH Authors Marwa Al-Badri, Shilton Dhaver, Osama Hamdy
Characterization of cognitive decline in long-duration type 1 diabetes by cognitive, neuroimaging and pathological examinations
JCI Insight / Clinical Research and Public Health / Jan 30
BILH Authors Hetal S Shah, Surya Vishva Teja Jangolla, Marc Gregory Yu, Rebecca S Roque, Amanda Hayes, John Gauthier, Nolan Ziemniak, Elizabeth Viebranz, I-Hsien Wu, Kyoungmin Park, Ward Fickweiler, Tanvi J Chokshi, Atif Adam, Jennifer K Sun, Lloyd Paul Aiello, George L King
Real-World Evaluation of i-gel Introduction on Intraoperative Airway-Related Safety Events: A Retrospective Cohort Study From a New England Hospital Network
Anesth Analg / Original Clinical Research Report / Feb 1
BILH Authors Salameh S Obeidat, Aiman Suleiman, Elena Ahrens, Matthew J Needham, Catriona Stewart, Mitra Khany, Tim M Tartler, Liana Zucco, Maximilian S Schaefer, Satya Krishna Ramachandran
Teens with Type 1 Diabetes and Executive Function Challenges Who Use Insulin Pumps Have Lower A1C Without Increased Risk of Diabetic Ketoacidosis or Severe Hypoglycemia
Diabetes Technol Ther / Research Article / Feb 6
BILH Authors Rebecca J Vitale, Liane J Tinsley, Lisa K Volkening, Lori M Laffel
Lrtm1 - A Novel Sensor of Insulin Signaling and Regulator of Metabolism and Activity
Diabetes/ Metabolism / Feb 7
BILH Authors Yingying Yu, Guoxiao Wang, Wenqiang Chen, Xiangyu Liu, Vitor Rosetto Munoz, Weikang Cai, Antonio S Gomes, C Ronald Kahn
Differential Effects of Retinol-Binding Protein 3 and Anti-VEGF Antibodies on Retinal Dysfunctions in Diabetic Retinopathy
Diabetes / Complications / Feb 13
BILH Authors Qin Li, Satoru Onizuka, Kyoungmin Park, Mingming Ma, Ward Fickweiler, Hyunseok Park, Qian Li, Fabricio Simao, Jared Boisclair, Maha Sharawy, I-Hsien Wu, Marc Gregory Yu, Lloyd P Aiello, Jennifer K Sun, George L King
Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies
Lancet Diabetes Endocrinol / Review / Feb 17
BILH Authors Medha Munshi
Dysregulated insulin signaling and inflammation contribute to the pathogenesis of Alzheimer's disease: from animal models to human cells
Neural Regen Res / Original Research Article / Feb 24
BILH Authors Wenqiang Chen
Soluble RAGE enhances muscle regeneration after cryoinjury in aged and diseased mice
PLoS One / Research / Feb 25
BILH Authors Amy J Wagers
About Joslin Diabetes Center
Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Part of Beth Israel Lahey Health, Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is affiliated with Harvard Medical School and one of only 18 NIH-designated Diabetes Research Centers in the United States.
